Zika virus affected baby born in Hawaii with microcephaly

The first case of brain damage linked to the Zika virus within the United States has been reported in Hawaii. The Hawaii State Department of Health said Friday that a baby born in an Oahu hospital with microcephaly — an unusually small head and brain — had been infected with the Zika virus, which is … Read more

50% Probiotics brand found contaminated with traces of gluten in USA

New Study Finds that Many Probiotics Are Contaminated with Traces of Gluten – Is my probiotic pack gluten-free? More than half of popular probiotics contain traces of gluten, according to an analysis performed by investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC). Tests on 22 top-selling probiotics revealed that 12 of them (or 55%) had detectable gluten.

A new antibody therapy shows promise in suppressing HIV infection

In first human study, new antibody therapy shows promise in suppressing HIV infection – In first human study, new antibody therapy shows promise in suppressing HIV infection. The new study, conducted in Michel Nussenzweig’s Laboratory of Molecular Immunology, finds that administration of a potent antibody, called 3BNC117, can catch HIV off guard and reduce viral loads.

Middle aged active have low risk of sudden cardiac arrest

Middle-aged athletes at low risk for sudden cardiac arrest while exercising — Physically active middle-aged adults have low risk of sudden cardiac arrest – Sudden cardiac arrest during sports activities is relatively low among physically active middle-aged adults, and older people can exercise without worrying about triggering a heart rhythm disturbance, revealed by American researchers.

Junk food consumed late in pregnancy more harmful to the child

Junk food consumed late in pregnancy has the potential to be more harmful to the child – “Too much junk food consumed late in pregnancy for humans has the potential to be more harmful to the child than excess junk food early in the pregnancy,” says Dr Jessica Gugusheff, post-doctoral researcher in the School of Agriculture, Food and Wine at University of Adelaide.

Provenge – Sipuleucel-T may have added benefit in prostate cancer

Sipuleucel-T in prostate cancer: Indication of added benefit – Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.

Do NOT follow this link or you will be banned from the site!